
Industrials · NSE / BSE
Founded in 2001 by Mr. Dhirajlal Kotadia, Sahajanand Medical Technologies Ltd. is a medical device company that focuses on advanced Class III and Class C/D devices used mainly in vascular and structural heart treatments. The company was the first in the world to receive CE certification for a drug-eluting stent with a biodegradable polymer called Infinnium. Its product range includes coronary stents and balloons for vascular interventions, technologies like TAVI and occluders for structural heart treatments, as well as renal stents and drug-coated balloons. The company operates R&D centres in India and Thailand and has a strong innovation base with over 100 granted patents and several pending applications. Its key products, including Supraflex Cruz, Hydra, and Cocoon, are supported by multiple clinical studies and are used in more than 76 countries. Sahajanand follows a global distribution strategy combining direct sales, hybrid models, and distributor partnerships across different markets. As of March 31, 2025, the company had over 1,400 employees along with consultants and contract staff supporting its operations.
Price Band
₹94 – ₹99
Issue Size
₹1768.30 L Cr
Lot Size
151 shares
GMP
-7.1%
Est. Listing
₹92
at current GMP
Subscribed
2.93x
overall
Open
25 Aug 2026
Close
28 Aug 2026
Allotment
31 Aug 2026
Refund
1 Sep 2026
Demat Credit
2 Sep 2026
Listing
2 Sep 2026
Overall Subscription
2.93x
Total Demand
QIB Multiplier
1.72x
Institutions & Funds
NII / HNI
3.55x
High Net-Worth
Retail (RII)
2.68x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 1,768,300 | 3,044,764 | 1.72x |
| NIB | 7,073,200 | 25,118,246 | 3.55x |
| HNIs(10L +) | 4,716,056 | 14,569,235 | 3.09x |
| HNIs (2-10L) | 2,357,144 | 10,549,011 | 4.48x |
| RETAIL | 8,841,500 | 23,681,481 | 2.68x |
| Total | 24,756,200 | 76,962,737 | 2.93x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| RETAIL | 58,553 | 136,956 | 2.34x |
| HNIs(10L +) | 2,231 | 1,134 | 0.51x |
| HNIs (2-10L) | 1,115 | 4,031 | 3.62x |
| Total Applications | 61,899 | 142,121 | 2.30x |
Annu Projects Limited is bringing an initial public offering (IPO) in the Industrials sector with an aggregate issue size of ₹1,76,83,000 Crores. The shares are offered at a price band of ₹94 to ₹99 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2026-08-28, the basis of allotment is scheduled to be finalized on 2026-08-31. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
The Annu Projects Limited IPO aggregate issue size is ₹1,76,83,000 Crores with an equity price band set at ₹94 to ₹99 per equity share. The retail lot size is 151 shares requiring a minimum capital outlay of approx. ₹14,949.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. You can track QIB, NII/HNI, and Retail category multiples directly on our dedicated live subscription page.
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2026-08-31.